---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-233429"
form_type: "8-K"
ticker: "OFIX"
cik: "0000884624"
company_name: "Orthofix Medical Inc."
filed_at: "2026-05-21T12:00:44+00:00"
generated_at: "2026-05-21T12:07:07.888164+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Orthofix cuts FY2026 guidance as CMS cuts bone stimulator reimbursement ~10%

## Summary
- CMS reduced Medicare reimbursement for HCPCS codes E0747, E0748, E0760 by ~10% effective May 18, 2026.
- FY2026 net sales guidance lowered to $838M-$848M; non-GAAP adjusted EBITDA to $90M-$93M.
- Company no longer expects positive free cash flow in FY2026; three-year financial targets abandoned.
- Further CMS changes could require additional outlook revisions; long-term impact still being evaluated.

## SEC filing metadata
- accession: 0001193125-26-233429
- form_type: 8-K
- ticker: OFIX
- cik: 0000884624
- company_name: Orthofix Medical Inc.
- filed_at: 2026-05-21T12:00:44+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/884624/000119312526233429/0001193125-26-233429-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/884624/000119312526233429/ofix-20260521.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-233429
- JSON: https://secwatch.observer/filing/0001193125-26-233429.json
- Plain text: https://secwatch.observer/filing/0001193125-26-233429.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.